70 Kristensen SL, Rorth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al
This is a key reason many clinicians consider it a safer and more physiologically intelligent approach
A pooled analysis of 1108 population-representative studies with 141 million participants
In one extension study, participants taking tirzepatide reduced their risk of progressing from prediabetes to type 2 diabetes by as much as 94% compared to placebo
So many of my patients are still unable to pay $300 out of pocket, so access to our most socially vulnerable patients is going to continue to be an issue in 2026. Wegovy is also approved to reduce the risk of heart attack, stroke or death in adults with overweight or obesity and established heart disease